140 related articles for article (PubMed ID: 8777565)
1. 5-Lipoxygenase-activating protein (FLAP).
Vickers PJ
J Lipid Mediat Cell Signal; 1995 Oct; 12(2-3):185-94. PubMed ID: 8777565
[No Abstract] [Full Text] [Related]
2. 5-lipoxygenase and FLAP.
Peters-Golden M; Brock TG
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):99-109. PubMed ID: 12895592
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of leukotriene biosynthesis.
Ford-Hutchinson AW
Ann N Y Acad Sci; 1991; 629():133-42. PubMed ID: 1952545
[No Abstract] [Full Text] [Related]
4. Regulation of the biosynthesis of the sulphido-leukotrienes.
Ford-Hutchinson AW
Adv Exp Med Biol; 1997; 400B():841-7. PubMed ID: 9547637
[No Abstract] [Full Text] [Related]
5. FLAP: a novel drug target for inhibiting the synthesis of leukotrienes.
Ford-Hutchinson AW
Trends Pharmacol Sci; 1991 Feb; 12(2):68-70. PubMed ID: 2024291
[TBL] [Abstract][Full Text] [Related]
6. The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein.
Bell RL; Harris RR
Clin Rev Allergy Immunol; 1999; 17(1-2):91-109. PubMed ID: 10436861
[No Abstract] [Full Text] [Related]
7. 5-Lipoxygenase.
Ford-Hutchinson AW; Gresser M; Young RN
Annu Rev Biochem; 1994; 63():383-417. PubMed ID: 7979243
[No Abstract] [Full Text] [Related]
8. The effect of 5-lipoxygenase-activating protein (FLAP) on substrate utilization by 5-lipoxygenase.
Vickers PJ; Deluca C; Wong E; Abramovitz M
Adv Exp Med Biol; 1997; 400A():145-51. PubMed ID: 9547550
[No Abstract] [Full Text] [Related]
9. Expression, purification and crystallization of human 5-lipoxygenase-activating protein with leukotriene-biosynthesis inhibitors.
Xu S; McKeever BM; Wisniewski D; Miller DK; Spencer RH; Chu L; Ujjainwalla F; Yamin TT; Evans JF; Becker JW; Ferguson AD
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Dec; 63(Pt 12):1054-7. PubMed ID: 18084092
[TBL] [Abstract][Full Text] [Related]
10. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.
Dixon RA; Diehl RE; Opas E; Rands E; Vickers PJ; Evans JF; Gillard JW; Miller DK
Nature; 1990 Jan; 343(6255):282-4. PubMed ID: 2300173
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the production and action of leukotrienes by MK-571 and MK-886.
Ford-Hutchinson AW
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():9-16. PubMed ID: 1847788
[No Abstract] [Full Text] [Related]
12. An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis.
Gerstmeier J; Weinigel C; Barz D; Werz O; Garscha U
Biochim Biophys Acta; 2014 Sep; 1840(9):2961-9. PubMed ID: 24905297
[TBL] [Abstract][Full Text] [Related]
13. Linoleic acid peroxidation by Solanum tuberosum lipoxygenase was activated in the presence of human 5-lipoxygenase-activating protein.
Battu S; Moalic S; Rigaud M; Beneytout JL
Biochim Biophys Acta; 1998 Jun; 1392(2-3):340-50. PubMed ID: 9630716
[TBL] [Abstract][Full Text] [Related]
14. Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling.
Lammers CH; Schweitzer P; Facchinetti P; Arrang JM; Madamba SG; Siggins GR; Piomelli D
J Neurochem; 1996 Jan; 66(1):147-52. PubMed ID: 8522947
[TBL] [Abstract][Full Text] [Related]
15. A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells.
Kargman S; Vickers PJ; Evans JF
J Cell Biol; 1992 Dec; 119(6):1701-9. PubMed ID: 1469057
[TBL] [Abstract][Full Text] [Related]
16. Roles of 5-lipoxygenase activating protein in cell proliferation and apoptosis.
Wu X; Biswal SS; Kehrer JP
Cell Biol Toxicol; 2003 Jun; 19(3):135-43. PubMed ID: 12945742
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
Voelkel NF; Tuder RM; Wade K; Höper M; Lepley RA; Goulet JL; Koller BH; Fitzpatrick F
J Clin Invest; 1996 Jun; 97(11):2491-8. PubMed ID: 8647941
[TBL] [Abstract][Full Text] [Related]
18. Activation of leukotriene production in granulocytes: effects on cell activation.
Ford-Hutchinson AW
Immunol Ser; 1992; 57():87-106. PubMed ID: 1504152
[No Abstract] [Full Text] [Related]
19. 5-Lipoxygenase-activating protein homodimer in human neutrophils: evidence for a role in leukotriene biosynthesis.
Plante H; Picard S; Mancini J; Borgeat P
Biochem J; 2006 Jan; 393(Pt 1):211-8. PubMed ID: 16144515
[TBL] [Abstract][Full Text] [Related]
20. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly.
Garscha U; Voelker S; Pace S; Gerstmeier J; Emini B; Liening S; Rossi A; Weinigel C; Rummler S; Schubert US; Scriba GK; Çelikoğlu E; Çalışkan B; Banoglu E; Sautebin L; Werz O
Biochem Pharmacol; 2016 Nov; 119():17-26. PubMed ID: 27592027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
